BMS at EULAR 2021 Congress

Intended for U.S. scientific audiences only.

The European Congress of Rheumatology 2021 (EULAR 2021 Congress) is an important opportunity to review and share the latest breakthroughs and research for patients living with immune-mediated rheumatic diseases.

Our Data at the European Congress of Rheumatology

Read more about our key data being presented at the meeting.

At EULAR 2021, Bristol Myers Squibb is presenting data on four assets spanning multiple disease areas, including rheumatoid arthritis, psoriatic arthritis and lupus.

Our Science   

Our diverse, promising portfolio and pipeline is driven by our focus on offering innovative medicines that transform patients’ lives. Read about how our scientists are addressing some of the most challenging diseases of our time and advancing research across numerous immune-mediated diseases.

Lupus: Treatments, Research and Bristol Myers Squibb’s Dedication to Patients – A Q&A with Subhashis Banerjee >

Subhashis Banerjee, vice president & disease area head, Rheumatology and Dermatology, explains how we are leaving no stone unturned in our approach to lupus research. 

Pursuing Innovative Approaches to Advance Research for Psoriatic Disease >

Shalabh Singhal, executive director, development program lead, Rheumatology, explains how by targeting the tyrosine kinase 2 (TYK2) pathway, researchers can further our understanding of how to improve care for psoriatic disease.

Destination: The Impact of Precision Medicine in Disease Management for People With Immune-Mediated Diseases >

Brian Gavin, development lead, discusses precision medicine for immune-mediated diseases, including rheumatoid arthritis and systemic lupus erythematosus.

Our Precision-Focused Approach in Rheumatoid Arthritis and Beyond: A Q&A With Dr. Sean E. Connolly >

Sean E. Connolly, executive director, head of Clinical Evaluation and Collaborations, explains our precision medicine research approach and shares a video on the potential role of biomarkers.


Our research in immunology and rheumatology spans a number of diseases and pathways. Learn more below.

Biomarkers in Rheumatoid Arthritis >

Learn more how biomarkers in rheumatoid arthritis can provide clues to diagnosis, insights into overall prognosis and have the potential to inform treatment strategies.

TYK2 Pathway Infographic >

Learn about the scientific mechanism behind the TYK2 pathway and its role in immune-mediated diseases.

Psoriatic Arthritis Infographic >

Learn more about psoriatic arthritis, its symptoms and its potential impact on patients. 

Rheumatoid Arthritis Infographic >

Learn more about rheumatoid arthritis, an immune-mediated disease that affects patients worldwide.

Lupus Infographic >

Learn more about systemic lupus erythematosus (SLE) and how it can impact patients around the world.

Juvenile Idiopathic Arthritis (JIA) Infographic >

Learn more about JIA, its symptoms and effects on pediatric patients worldwide.

Immunology Pathways is a resource for U.S. healthcare professionals with information on immune-mediated diseases like psoriatic arthritis, including signs and symptoms and disease and clinical trial tools, emerging pathways involved in the pathogenesis of disease and videos and dynamic resources.